Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2021March 31, 2022

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                     to                      

Commission File Number: 001-35435

 

Proto Labs, Inc.

(Exact name of registrant as specified in its charter)

 

Minnesota

41-1939628

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

5540 Pioneer Creek Drive

 

Maple Plain, Minnesota

55359

(Address of principal executive offices)

(Zip Code)

 

(763) 479-3680

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, Par Value $0.001 Per Share

PRLB

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ☑Yes ☐No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  ☑Yes ☐No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer     

Non-accelerated filer

☐    

 

Smaller reporting company

Emerging growth company

    

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐Yes ☑No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 27,761,06327,496,142 shares of Common Stock, par value $0.001 per share, were outstanding at July 29, 2021.May 2, 2022.

 

 

 

 

Proto Labs, Inc.

TABLE OF CONTENTS

 

Item

 

Description

 

Page

 

 

 

 

 

PART I

1.

 

Financial Statements

 

2

2.

 

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

16

3.

 

Quantitative and Qualitative Disclosures about Market Risk

 

26

4.

 

Controls and Procedures

 

27

PART II

1.

 

Legal Proceedings

 

28

1A.

 

Risk Factors

 

28

2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

28

3.

 

Defaults Upon Senior Securities

 

28

4.

 

Mine Safety Disclosures

 

28

5.

 

Other Information

 

28

6.

 

Exhibits

 

29

Item

 

Description

 

Page

 

 

 

 

 

PART I

1.

 

Financial Statements

 

2

2.

 

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

16

3.

 

Quantitative and Qualitative Disclosures about Market Risk

 

24

4.

 

Controls and Procedures

 

25

PART II

1.

 

Legal Proceedings

 

26

1A.

 

Risk Factors

 

26

2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

26

3.

 

Defaults Upon Senior Securities

 

26

4.

 

Mine Safety Disclosures

 

26

5.

 

Other Information

 

26

6.

 

Exhibits

 

27

 

1

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

 

Proto Labs, Inc.

Consolidated Balance Sheets

(In thousands, except share and per share amounts)

 


 

 

June 30,

 

December 31,

  

March 31,

 

December 31,

 
 

2021

  

2020

  2022  2021 
 

(Unaudited)

    

(Unaudited)

   

Assets

            

Current assets

          

Cash and cash equivalents

 $41,909 $127,603  $57,239 $65,929 

Short-term marketable securities

 18,341 34,088  19,914 11,580 

Accounts receivable, net of allowance for doubtful accounts of $1,997 and $1,781 as of June 30, 2021 and December 31, 2020, respectively

 83,470 57,877 

Accounts receivable, net of allowance for doubtful accounts of $1,998 and $1,948 as of March 31, 2022 and December 31, 2021, respectively

 85,960 80,051 

Inventory

 9,111 10,862  14,227 13,161 

Income taxes receivable

 4,575 540  687 1,321 

Prepaid expenses and other current assets

  10,107   11,032   10,185   11,450 

Total current assets

 167,513  242,002  188,212  183,492 

Property and equipment, net

 288,495 282,666  270,946 280,346 

Goodwill

 407,191 128,752  398,319 400,610 

Other intangible assets, net

 41,674 14,350  36,234 37,998 

Long-term marketable securities

 28,700 59,357  28,196 14,340 

Operating lease assets

 8,801 9,855  4,800 5,578 

Finance lease assets

 2,147 2,396  1,773 1,898 

Long-term assets held for sale

 1,985 0 

Other long-term assets

  4,769   4,826   4,286   4,320 

Total assets

 $949,290  $744,204  $934,751  $928,582 
          

Liabilities and shareholders' equity

            

Current liabilities

          

Accounts payable

 $26,038 $18,248  $17,511 $25,364 

Accrued compensation

 14,930 11,989  13,094 13,704 

Accrued liabilities and other

 15,072 16,193  23,030 11,980 

Current contingent consideration

 2,936 0 

Current operating lease liabilities

 2,847 3,272  2,253 3,298 

Current finance lease liabilities

 554 552  493 550 

Income taxes payable

  40   0   3,870   0 

Total current liabilities

 62,417  50,254  60,251  54,896 

Long-term contingent consideration

 2,693 0 

Long-term operating lease liabilities

 7,097 7,586  2,514 2,245 

Long-term finance lease liabilities

 1,639 1,919  1,269 1,351 

Long-term deferred tax liabilities

 36,898 33,854  32,661 35,892 

Other long-term liabilities

  6,569   6,235   6,021   5,705 

Total liabilities

 117,313  99,848  102,716  100,089 
          

Shareholders' equity

          

Preferred stock, $0.001 par value, authorized 10,000,000 shares; issued and outstanding 0 shares as of each of June 30, 2021 and December 31, 2020

 0  0 

Common stock, $0.001 par value, authorized 150,000,000 shares; issued and outstanding 27,761,063 and 26,776,796 shares as of June 30, 2021 and December 31, 2020, respectively

 28 27 

Preferred stock, $0.001 par value, authorized 10,000,000 shares; issued and outstanding 0 shares as of each of March 31, 2022 and December 31, 2021

 0  0 

Common stock, $0.001 par value, authorized 150,000,000 shares; issued and outstanding 27,493,661 and 27,465,945 shares as of March 31, 2022 and December 31, 2021, respectively

 28 28 

Additional paid-in capital

 461,597 284,848  472,483 468,548 

Retained earnings

 378,467 362,901  381,829 376,734 

Accumulated other comprehensive loss

  (8,115)  (3,420)  (22,305)  (16,817)

Total shareholders' equity

  831,977   644,356   832,035   828,493 

Total liabilities and shareholders' equity

 $949,290  $744,204  $934,751  $928,582 

 


 

The accompanying notes are an integral part of these consolidated financial statements.

 

2

 

 

Proto Labs, Inc.

Consolidated Statements of Comprehensive Income

(In thousands, except share and per share amounts)

(Unaudited)

 


 

 

Three Months Ended

 

Six Months Ended

  

Three Months Ended

 
 

June 30,

  

June 30,

  

March 31,

 
 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

 
  

Statements of Operations:

            

Revenue

 $123,048 $106,575 $239,174 $221,683  $124,168  $116,126 

Cost of revenue

  66,423   54,119   127,219   111,127   68,364   60,796 

Gross profit

 56,625  52,456  111,955  110,556  55,804  55,330 

Operating expenses

  

Marketing and sales

 21,044 16,936 40,524 35,116  20,586  19,480 

Research and development

 11,060 8,648 23,241 17,635  10,557  12,181 

General and administrative

  8,417   12,521   27,825   26,629   16,771   19,408 

Total operating expenses

  40,521   38,105   91,590   79,380   47,914   51,069 

Income from operations

 16,104  14,351  20,365  31,176  7,890  4,261 

Other income (loss), net

  137   767  (176)  1,821 

Other loss, net

  (300)  (313)

Income before income taxes

 16,241  15,118  20,189  32,997  7,590  3,948 

Provision for income taxes

  3,326   2,511   3,562   6,406   2,495   236 

Net income

 $12,915  $12,607  $16,627  $26,591  $5,095  $3,712 
  

Net income per share:

  

Basic

 $0.47  $0.47  $0.60  $1.00  $0.19  $0.14 

Diluted

 $0.47  $0.47  $0.60  $0.99  $0.19  $0.13 
  

Shares used to compute net income per share:

  

Basic

 27,735,732 26,660,498 27,600,684 26,718,652  27,502,941  27,464,136 

Diluted

 27,744,870 26,760,866 27,741,464 26,837,938  27,510,477  27,698,195 
  

Comprehensive Income (net of tax)

        

Comprehensive income

 $14,896  $12,971  $11,932  $23,975 

Comprehensive Loss (net of tax)

    

Comprehensive loss

 $(393) $(2,964)

 


 

The accompanying notes are an integral part of these consolidated financial statements.

 

3

 

 

Proto Labs, Inc.

Consolidated Statements of Shareholders' Equity

(In thousands, except share amounts)

 


 

 

Common Stock

 

Additional

    

Accumulated Other

    

Common Stock

 

Additional

    

Accumulated Other

   
       

Paid-In

 

Retained

 

Comprehensive

          

Paid-In

 

Retained

 

Comprehensive

   
 

Shares

  

Amount

  

Capital

  

Earnings

  

Loss

  

Total

  

Shares

  

Amount

  

Capital

  

Earnings

  

Loss

  

Total

 
                          

Balance at January 1, 2021

 26,776,796  27  284,848  362,901  (3,420) 644,356 

Balance at January 1, 2022

 27,465,945 28 468,548 376,734 (16,817) 828,493 

Common shares issued on exercise of options and other, net of shares withheld for tax obligations

 48,955  0  (290) 0  0  (290) 27,716 - (462) - - (462)

Common shares issued for Hubs acquisition

 863,995  1  166,708  0  0  166,709 

Stock-based compensation expense

 -  0  5,620  0  0  5,620  - - 4,397 - - 4,397 

Repurchases of common stock

 0  0  0  0  0  0  0  -  -  -  -  - 

Net income

 -  0  0  3,712  0  3,712  - - - 5,095 - 5,095 

Other comprehensive loss

                                    

Foreign currency translation adjustment

 -  0  0  0  (6,842) (6,842) - - - - (4,972) (4,972)

Net unrealized gains (losses) on investments in securities

 -  0  0  0  166   166  - - - - (516)  (516)

Comprehensive loss

                      (2,964)      0   0   0   0   (393)

Balance at March 31, 2021

  27,689,746  $28  $456,886  $366,613  $(10,096) $813,431 

Common shares issued on exercise of options and other, net of shares withheld for tax obligations

 85,317 0 (81) 0 0 (81)

Stock-based compensation expense

 - 0 4,941 0 0 4,941 

Repurchases of common stock

 (14,000) 0 (149) (1,061) 0 (1,210)

Net income

 - 0 0 12,915 0 12,915 

Other comprehensive income

             

Foreign currency translation adjustment

 - 0 0 0 2,030 2,030 

Net unrealized gains (losses) on investments in securities

 - 0 0 0 (49)  (49)

Comprehensive income

                      14,896 

Balance at June 30, 2021

  27,761,063  $28  $461,597  $378,467  $(8,115) $831,977 

Balance at March 31, 2022

  27,493,661  $28  $472,483  $381,829  $(22,305) $832,035 

 

 

Common Stock

 

Additional

    

Accumulated Other

    

Common Stock

  

Additional

    

Accumulated Other

   
       

Paid-In

 

Retained

 

Comprehensive

          

Paid-In

 

Retained

 

Comprehensive

   
 

Shares

  

Amount

  

Capital

  

Earnings

  

Loss

  

Total

  

Shares

  

Amount

  

Capital

  

Earnings

  

Loss

  

Total

 
              

Balance at January 1, 2020

 26,786,459  27  268,059  324,722  (7,018) 585,790 

Balance at January 1, 2021

 26,776,796  27  284,848  362,901  (3,420) 644,356 

Common shares issued on exercise of options and other, net of shares withheld for tax obligations

 23,525  0  (902) 0  0  (902) 48,955  -  (290) -  -  (290)

Common shares issued for Hubs acquisition

 863,995  1  166,708  0  0  166,709 

Stock-based compensation expense

 -  0  3,033  0  0  3,033  -  -  5,620  -  -  5,620 

Repurchases of common stock

 (161,460) 0  (1,616) (9,569) 0  (11,185) 0  -  -  -  -  - 

Net income

 -  0  0  13,984  0  13,984  -  -  -  3,712  -  3,712 

Other comprehensive income

                  

Other comprehensive loss

              

Foreign currency translation adjustment

 -  0  0  0  (2,980)  (2,980) -  -  -  -  (6,842) (6,842)

Comprehensive income

                      11,004 

Balance at March 31, 2020

  26,648,524  $27  $268,574  $329,137  $(9,998) $587,740 

Common shares issued on exercise of options and other, net of shares withheld for tax obligations

 96,186  0  400  0  0  400 

Stock-based compensation expense

 -  0  3,639  0  0  3,639 

Repurchases of common stock

 (38,154) 0  (382) (3,119) 0  (3,501)

Net income

 -  0  0  12,607  0  12,607 

Other comprehensive income

                  

Foreign currency translation adjustment

 -  0  0  0  364   364 

Comprehensive income

                      12,971 

Balance at June 30, 2020

  26,706,556  $27  $272,231  $338,625  $(9,634) $601,249 

Net unrealized gains (losses) on investments in securities

 -  -  -  -  166   166 

Comprehensive loss

      0   0   0   0   (2,964)

Balance at March 31, 2021

  27,689,746  $28  $456,886  $366,613  $(10,096) $813,431 

 


 

The accompanying notes are an integral part of these consolidated financial statements.

 

4

 

 

Proto Labs, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 


 

 

Six Months Ended

  

Three Months Ended

 
 

June 30,

  

March 31,

 
 

2021

  

2020

  

2022

  

2021

 
      

Operating activities

          

Net income

 $16,627  $26,591  $5,095  $3,712 

Adjustments to reconcile net income to net cash provided by operating activities:

      

Depreciation and amortization

 20,127 15,855  10,232  10,059 

Stock-based compensation expense

 10,561 6,672  4,397  5,620 

Deferred taxes

 419 5,651  (3,213) (69)

Amortization of marketable securities

 261 129 

Realized gain on available-sale-securities

 (117) 0 

Fair value of contingent consideration

 (7,763) 0 

Other

 125 (854) 79  126 

Changes in operating assets and liabilities:

      

Accounts receivable

 (23,296) (4,292) (6,329) (14,558)

Inventories

 1,727 (801) (675) 917 

Prepaid expenses and other

 1,810 (1,068) 1,110  2,696 

Income taxes

 (4,015) (1,341) 4,519  (183)

Accounts payable

 5,011 1,082  (326) 669 

Accrued liabilities and other

  (748)  5,793   2,894   (2,564)

Net cash provided by operating activities

  20,729   53,417   17,783   6,425 
      

Investing activities

          

Purchases of property, equipment and other capital assets

 (23,929) (33,305) (3,069) (6,546)

Cash used for acquisitions, net of cash acquired

 (127,413) 0  0  (127,709)

Purchases of other assets and investments

 0 (3,000)

Purchases of marketable securities

 (15,159) (57,212) (29,366) (8,227)

Proceeds from sales of marketable securities

 47,694 0  0  45,194 

Proceeds from maturities of marketable securities

  13,725  28,225 

Proceeds from call redemptions and maturities of marketable securities

  6,600   7,155 

Net cash used in investing activities

  (105,082)  (65,292)  (25,835)  (90,133)
      

Financing activities

          

Proceeds from exercises of stock options

 3,838 2,855  6  1,704 

Purchases of shares withheld for tax obligations

 (4,209) (3,367) (468) (1,994)

Repurchases of common stock

 (1,210) (14,686)

Principal repayments of finance lease obligations

  (275)  0   (139)  (137)

Net cash used in financing activities

  (1,856)  (15,198)  (601)  (427)

Effect of exchange rate changes on cash and cash equivalents

  515  (149)  (37)  306 

Net decrease in cash and cash equivalents

 (85,694) (27,222) (8,690) (83,829)

Cash and cash equivalents, beginning of period

  127,603   125,225   65,929   127,603 

Cash and cash equivalents, end of period

 $41,909  $98,003  $57,239  $43,774 

 


 

The accompanying notes are an integral part of these consolidated financial statements.

 

5

 

 

Note 1 – Basis of Presentation

 

The unaudited interim Consolidated Financial Statements of Proto Labs, Inc. (Protolabs, the Company, we, us or our) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the accompanying financial statements reflect all adjustments necessary for a fair presentation of the Company’s statements of financial position, results of operations and cash flows for the periods presented. Except as otherwise disclosed herein, these adjustments consist of normal, recurring items. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.

 

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. For further information, refer to the audited Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 20202021 as filed with the Securities and Exchange Commission (SEC) on February 19, 2021.18, 2022.

 

The accompanying Consolidated Balance Sheet as of December 31, 20202021 was derived from the audited Consolidated Financial Statements but does not include all disclosures required by U.S. GAAP for a full set of financial statements. This Form 10-Q should be read in conjunction with the Company’s Consolidated Financial Statements and Notes included in the Annual Report on Form 10-K filed on February 19, 202118, 2022 as referenced above.

  

 

Note 2 – Recent Accounting Pronouncements

 

Recently Adopted Accounting Pronouncements

In December 2019, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) 2019-12,Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12). ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The Company adopted ASUdid 2019-12not on January 1, 2021 and there was norecently adopt any accounting pronouncements that had a material impact on the Company’s consolidated financial statements.Company's Consolidated Financial Statements.

 

 

Note 3 – Net Income per Common Share

 

Basic net income per share is computed based on the weighted-average number of common shares outstanding. Diluted net income per share is computed based on the weighted-average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had potentially dilutive common shares been issued and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options restricted stock units and restricted stockother stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. Performance stock units are excluded from the calculation of dilutive potential common shares until the performance conditions have been satisfied. For the three months ended March 31, 2022, 233,380 anti-dilutive options were excluded from the calculation of diluted weighted average shares outstanding.

 

The table below sets forth the computation of basic and diluted net income per share:

 


 

 

Three Months Ended

 

Six Months Ended

  

Three Months Ended

 
 

June 30,

  

June 30,

  

March 31,

 

(in thousands, except share and per share amounts)

 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

 

Net income

 $12,915  $12,607  $16,627  $26,591  $5,095  $3,712 
  

Basic - weighted-average shares outstanding:

 27,735,732  26,660,498  27,600,684  26,718,652  27,502,941  27,464,136 

Effect of dilutive securities:

  

Employee stock options and other

  9,138   100,368   140,780   119,286   7,536   234,059 

Diluted - weighted-average shares outstanding:

  27,744,870   26,760,866   27,741,464   26,837,938   27,510,477   27,698,195 

Net income per share:

  

Basic

 $0.47  $0.47  $0.60  $1.00  $0.19  $0.14 

Diluted

 $0.47  $0.47  $0.60  $0.99  $0.19  $0.13 

 


 

6

 

Note 4 – Business Combinations

 

On January 22, 2021, the Company acquired all of the outstanding shares of 3D Hubs, Inc. (“Hubs”)(Hubs), for $294.1 million, consisting of $127.4 million in cash and 863,995 shares of the Company's common stock valued at $166.7 million on the date of close. Up to anclosing date. The purchase agreement included additional $52.8 million of contingent consideration is payable after closing,of up to $52.8 million subject to the satisfactionachievement of performance-based targets during fiscal year 2021 and fiscal year 2022,2022. consistingThe contingent consideration consisted of up to $25.0 million in cash and up to 143,983 shares of the Company's common stock valued at $27.8 million on the dateclosing date. The Company initially recorded a liability of close.$13.6 million related to the contingent consideration, which was subsequently reversed when it was determined the performance based targets would not be met in 2021 and the expectation that those targets would not be met in fiscal 2022. The reversal of the contingent consideration was recorded as a decrease in general and administrative expense in the Consolidated Statements of Comprehensive Income.

 

Hubs is based in Amsterdam, Netherlands and is a leading online manufacturing platform that provides customers with on-demand access to a global network of premium manufacturing partners. The acquisition enhances the Company’s value proposition by expanding the customer offerings, enabling the Company to more holistically serve its customers.

 

The fair value of the consideration paid for this acquisition has been allocated on a preliminary basis to the assets purchased and liabilities assumed based on their estimated fair values as of the acquisition date, with any excess recorded as goodwill.  The goodwill associated with the acquisition represents both the strategic and growth opportunities by significantly expanding the customer offering with a network of premium manufacturing partners. The goodwill related to the acquisition is not deductible for tax purposes. 

 

The Company recorded a contingent consideration liability of $13.6 million as of the acquisition date representing the estimated fair value of the amounts payable to former shareholders, as outlined under the terms of the merger agreement, payable subject to the satisfaction of performance-based targets during fiscal year 2021 and fiscal year 2022, consisting of up to $25.0 million in cash and up to 143,983 shares of the Company's common stock valued at $27.8 million on the date of close. The fair value of the contingent consideration (Level 3) is determined using a Monte Carlo pricing model. In the second quarter of 2021, the Company recorded a $7.8 million decrease to the estimated fair value of the contingent consideration liabilities, which was included as a decrease in general and administrative expense in the Consolidated Statements of Comprehensive Income. Fluctuations due to foreign currency translation have been recorded in the Consolidated Statements of Shareholders’ Equity.

The results of Hubs since the date of acquisition have been included with Protolabs' results. Pro forma disclosures of the consolidated results of the Company with the full year effects of Hubs, as if the acquisition had occurred on January 1, 2020, are not required and have not been separately presented since the impact to the Company's results of operations was not material.

The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC 805, Business Combinations. In the second quarter of 2021, the Company recorded adjustments to the preliminary allocation, including a $3.9 million decrease to intangible assets, a $6.4 million increase to goodwill, a $3.3 million increase to contingent consideration, a $0.5 million decrease to deferred tax liabilities, and a decrease to cash paid of $0.3 million. The adjustments were driven by changes to the preliminary valuation and finalization of the working capital calculation. As of June 30, 2021, the allocation of purchase price to assets and liabilities is preliminary. Thefinal purchase price allocation will be finalized in 2021. The preliminary allocation iswas as follows:


 

(in thousands)

 Acquisition  Acquisition 

Assets acquired:

    

Current assets

 $2,497  $2,497 

Intangible assets

 30,770  30,770 

Goodwill

 281,845  280,925 

Other long-term assets

  1,139   1,139 

Total assets acquired

  316,251   315,331 
  

Liabilities assumed:

    

Current contingent consideration

 7,093  7,093 

Current liabilities

 5,666  5,666 

Long-term contingent consideration

 6,507  6,507 

Long-term deferred tax liabilities

 2,608  1,688 

Other long-term liabilities

  255   255 

Total liabilities assumed

  22,129   21,209 

Net assets acquired

  294,122   294,122 
  

Cash paid

 133,847  133,847 

Cash acquired

  (6,434)  (6,434)

Net cash consideration

 127,413  127,413 

Equity portion of purchase price

  166,709   166,709 

Total purchase consideration

 $294,122  $294,122 

 


 

7

 

Note 5 – Goodwill and Other Intangible Assets

 

The changes in the carrying amount of goodwill during the sixthree months ended June 30, 2021March 31, 2022 were as follows:

 


 

(in thousands)

 Six Months Ended June 30, 2021  Three Months Ended March 31, 2022 

Balance as of the beginning of the period

 $128,752  $400,610 

Goodwill acquired during the period

 281,845  0 

Foreign currency translation adjustments

  (3,406)  (2,291)

Balance as of the end of the period

 $407,191  $398,319 

 


 

Goodwill increased $281.8 million during the six months ended June 30, 2021 as a result of our acquisition of Hubs. Goodwill has been allocated to the acquired Hubs entities consisting of goodwill of €106.5 million in Europe and $152.2$151.3 million in the United States as of the date of the acquisition. The Euro denominated goodwill is translated at the end of each period using the current exchange rates resulting in a foreign currency translation adjustment that is recorded as a component of Other Comprehensive Income.

 

Intangible assets other than goodwill at June 30, 2021March 31, 2022 and December 31, 20202021 were as follows:

 


 

 

June 30, 2021

  

December 31, 2020

  

Useful

 

Weighted Average

 

March 31, 2022

  

December 31, 2021

  

Useful

  

Weighted Average

 

(in thousands)

 

Gross

  

Accumulated Amortization

  

Net

  

Gross

  

Accumulated Amortization

  

Net

  

Life (in years)

 

Useful Life Remaining (in years)

 

Gross

  

Accumulated Amortization

  

Net

  

Gross

  

Accumulated Amortization

  

Net

  

Life (in years)

  

Useful Life Remaining (in years)

 

Intangible assets with finite lives:

                                 

Marketing assets

 $930 $(667) $263 $930 $(620) $310 10.0 2.8 $930  $(736) $194  $930  $(713) $217  10.0  2.0 

Non-compete agreement

 853 (297) 556 270 (238) 32 2.0 - 5.0 3.3 836  (393) 443  842  (363) 479  2.0 - 5.0  2.7 

Software technology

 13,229 (4,330) 8,899 13,229 (3,645) 9,584 10.0 7.0 13,229  (5,356) 7,873  13,229  (5,014) 8,215  10.0  6.3 

Software platform

 27,170 (1,089) 26,081 0 0  0 10.0 9.6 26,432  (2,724) 23,708  26,725  (2,262) 24,463  12.0  10.8 

Tradenames

 365 (51) 314 0 0  0 3.0 2.6 355  (142) 213  359  (114) 245  3.0  1.8 

Customer relationships

 12,292  (6,731) 5,561  10,070  (5,646) 4,424  3.0 - 9.0 2.3  12,228   (8,425)  3,803   12,252   (7,873)  4,379  3.0 - 9.0  1.6 

Total intangible assets

 $54,839  $(13,165) $41,674  $24,499  $(10,149) $14,350      $54,010  $(17,776) $36,234  $54,337  $(16,339) $37,998      

 


 

Intangible assets increased $30.8 million during the six months ended June 30, 2021 as a result of our acquisition of Hubs. Intangible assets have been allocated to the acquired Hubs entities consisting of intangible assets of €11.6 million in Europe and $16.6 million in the United States as of the date of the acquisition. The Euro denominated intangible assets are translated at the end of each period using the current exchange rates resulting in a foreign currency translation adjustment that is recorded as a component of Other Comprehensive Income. Foreign currency losses related to intangible assets were $0.4$1.2 and $0.9 million as of June 30, 2021. March 31, 2022There was 0 foreign currency translation impact as of and December 31, 2020.2021, respectively. Amortization expense for intangible assets was $1.5 million and $0.8 million for each of the three months ended June 30, 2021March 31, 2022 and 20202021, respectively, and $3.0 million and $1.5 million for the six months ended June 30, 2021 and 2020, respectively..

 

Estimated aggregated amortization expense based on the current carrying value of the amortizable intangible assets and current exchange rates is as follows:

 


 

(in thousands)

 

Estimated Amortization Expense

  

Estimated Amortization Expense

 

Remaining 2021

 $3,130 

2022

 6,259 

Remaining 2022

 $4,608 

2023

 6,056  5,940 

2024

 3,832  3,770 

2025

 3,750  3,670 

2026

 3,567 

Thereafter

  18,647   14,679 

Total estimated amortization expense

 $41,674  $36,234 

 


 

8

Note 6 Assets Held for Sale

Assets are classified as held for sale and presented separately on the Consolidated Balance Sheet when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the assets; (2) the assets are available for immediate sale, in their present condition, subject only to terms that are usual and customary for sales of such assets; (3) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (4) the sale of the assets is probable and is expected to be completed within one year; (5) the assets are being actively marketed for a price that is reasonable in relation to their current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or the plan will be withdrawn. The assets are then recorded at the lower of their current carrying value or the fair market value, less costs to sell.

During the first quarter of 2022, a facility the Company owns in Maple Plain, Minnesota, encompassing approximately 35,000 square feet of manufacturing and office space, met the criteria to be held for sale. The assets held for sale were $2.0 million as of March 31, 2022 and are presented on the Company's Consolidated Balance Sheet as Long-term assets held for sale.  The assets held for sale had no impact on the Company’s Consolidated Statements of Operations during the three months ended March 31, 2022. The Company expects to sell the facility during fiscal 2022.

 

 

Note 67 – Fair Value Measurements

 

Accounting Standards Codification, Fair Value Measurement (ASC 820), defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

 

Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

The Company's assets and liabilities that are required to be measured or disclosed at fair value on a recurring basis include cash and cash equivalents and marketable securities and contingent consideration.securities. The Company’s cash consists of bank deposits. The Company’s cash equivalents measured at fair value consist of money market mutual funds. The Company determines the fair value of these investments using Level 1 inputs. The Company's marketable securities consist of short-term and long-term agency, municipal, corporate and other debt securities. Fair value for the corporate debt securities is primarily determined based on quoted market prices (Level 1). Fair values for the U.S. municipal securities, U.S. government agency securities, certificates of deposit and U.S. treasury securities are primarily determined using dealer quotes or quoted market prices for similar securities (Level 2). The Company's contingent consideration is the current fair value estimate of amounts owed to the former shareholders of Hubs and is determined using the Monte Carlo pricing model (Level 3).

 

The following table summarizes financial assets as of June 30, 2021March 31, 2022 and December 31, 20202021 measured at fair value on a recurring basis: 

 


 

  

June 30, 2021

  

December 31, 2020

 

(in thousands)

 

Level 1

  

Level 2

  

Level 3

  

Level 1

  

Level 2

  

Level 3

 

Financial Assets:

                        

Cash and cash equivalents

 $40,694  $0  $0  $72,225  $0  $0 

Money market mutual fund

  1,215   0   0   55,378   0   0 

Marketable securities

  17,951   29,090   0   0   0   0 

Total

 $59,860  $29,090  $0  $127,603  $0  $0 

Financial Liabilities:

                        

Contingent consideration

 $0  $0  $5,629  $0  $0  $0 

Total

 $0  $0  $5,629  $0  $0  $0 

  

March 31, 2022

  

December 31, 2021

 

(in thousands)

 

Level 1

  

Level 2

  

Level 3

  

Level 1

  

Level 2

  

Level 3

 

Financial Assets:

                        

Cash and cash equivalents

 $49,569  $0  $0  $65,637  $0  $0 

Money market mutual fund

  7,670   0   0   292   0   0 

Marketable securities

  22,251   25,859   0   7,602   18,318   0 

Total

 $79,490  $25,859  $0  $73,531  $18,318  $0 

 

In the first quarter of 2021, the Company sold held-to-maturity securities in order to partially fund the acquisition of Hubs. As a result of the sale, all remaining marketable securities were reclassified to available-for-sale securities and reported at fair value.

The Company recorded a contingent consideration liability at the acquisition date of Hubs representing the amounts payable to former shareholders, as outlined under the terms of the merger agreement, payable subject to the satisfaction of performance-based targets during fiscal year 2021 and fiscal year 2022, consisting of up to $25.0 million in cash and up to 143,983 shares of the Company's common stock valued at $27.8 million on the date of close. The fair value of the contingent consideration (Level 3) is determined using a Monte Carlo pricing model. Subsequent changes in the fair value of the contingent consideration liabilities have been recorded in the Consolidated Statements of Comprehensive Income. Fluctuations due to foreign currency translation have been recorded in the Consolidated Statements of Shareholders’ Equity.

 

Note 78 – Marketable Securities

 

The Company invests in short-term and long-term agency, municipal, corporate and other debt securities. As of June 30, 2021 theThe securities are categorized as available-for-sale and are recorded at fair value. As of December 31, 2020, the securities were categorized as held-to-maturity and were recorded at amortized cost, net of an allowance for credit losses. The change in categorization was a result of the sale of securities in the first quarter of 2021 in order to partially fund the acquisition of Hubs and did not have a material impact on our financial statements. The following table summarizes information regarding the Company’s short-term and long-term marketable securities as of June 30, 2021March 31, 2022 and December 31, 20202021:

 


 

 

June 30, 2021

  

March 31, 2022

 

(in thousands)

 

Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

  

Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

 

U.S. municipal securities

 $20,968 $43 $(17) $20,994  $14,889 $0 $(264) $14,625 

Corporate debt securities

 19,062 68 (29) 19,101  12,144 0 (180) 11,964 

U.S. government agency securities

 1,500 0 (2) 1,498  17,288 0 (188) 17,100 

Certificates of deposit/time deposits

  5,394   54   0   5,448  1,438 2 (2) 1,438 

Commercial paper

  2,987   0   (4)  2,983 

Total marketable securities

 $46,924  $165  $(48) $47,041  $48,746  $2  $(638) $48,110 

 


 

9

 

 

 

December 31, 2020

  

December 31, 2021

 

(in thousands)

 

Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

  

Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

 

U.S. municipal securities

 $25,003  $83  $(2) $25,084  $12,549  $0  $(70) $12,479 

Corporate debt securities

 42,048  211  (11) 42,248  9,303  0  (44) 9,259 

U.S. government agency securities

 18,500  6  (10) 18,496  2,500  0  (12) 2,488 

Certificates of deposit/time deposits

 5,395  93  0  5,488  1,687  7  0  1,694 

Commercial paper

  2,499   0   0   2,499   0   0   0   0 

Total marketable securities

 $93,445  $393  $(23) $93,815  $26,039  $7  $(126) $25,920 

 


 

Fair values for the corporate debt securities are primarily determined based on quoted market prices (Level 1). Fair values for the U.S. municipal securities, U.S. government agency securities, certificates of deposit and U.S. treasury securities are primarily determined using dealer quotes or quoted market prices for similar securities (Level 2).

 

During the first quarter of 2020, the Company adopted the FASB ASU 2016-13,Financial Instruments – Credit Losses. The Company calculated the expected credit loss for each security in its portfolio using the probability-of-default method. The Company concluded the adoption of the guidance had no material impact on its consolidated financial statements. 

Classification of marketable securities as current or non-current is based upon the security’s maturity date as of the date of these financial statements.

 

The June 30, 2021March 31, 2022 balance of available-for-sale debt securities by contractual maturity is shown in the following table at fair value. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.

 


 

 

June 30,

  

March 31,

 

(in thousands)

 

2021

  2022 

Due in one year or less

 $18,341  $19,914 

Due after one year through five years

  28,700   28,196 

Total marketable securities

 $47,041  $48,110 

 


 

 

Note 89 – Inventory

 

Inventory consists primarily of raw materials, which are recorded at the lower of cost or marketand net realizable value using the standard cost method, which approximates first-in, first-out (FIFO) cost. The Company periodically reviews its inventory for slow-moving, damaged and discontinued items and provides allowances to reduce such items identified to their recoverable amounts.

 

The Company’s inventory consisted of the following as of the dates indicated:

 


 

 

June 30,

 

December 31,

  

March 31,

 

December 31,

 

(in thousands)

 

2021

  

2020

  2022  2021 

Total inventory

 $9,395 $11,122  $14,994 $13,474 

Allowance for obsolescence

  (284)  (260)  (767)  (313)

Inventory, net of allowance

 $9,111  $10,862  $14,227  $13,161 

 


 

10

 

Note 910 – Stock-Based Compensation

 

Under the Company’s 2012 Long-Term Incentive Plan, as amended (the 2012 Plan), the Company has the ability to grant stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, other stock-based awards and cash incentive awards. Awards under the 2012 Plan have a maximum term of ten years from the date of grant. The compensation committee may provide that the vesting or payment of any award will be subject to the attainment of specified performance measures in addition to the satisfaction of any continued service requirements and the compensation committee will determine whether such measures have been achieved. The per-share exercise price of stock options and SARs granted under the 2012 Plan generally may not be less than the fair market value of a share of our common stock on the date of the grant.

 

Employee Stock Purchase Plan

 

The Company’s 2012 Employee Stock Purchase Plan (ESPP) allows eligible employees to purchase a variable number of shares of the Company’s common stock each offering period at a discount through payroll deductions of up to 15 percent of their eligible compensation, subject to plan limitations. The ESPP provides for six-month offering periods with a single purchase period ending May 15 and November 15, respectively. At the end of each offering period, employees are able to purchase shares at 85 percent of the lower of the fair market value of the Company’s common stock on the first trading day of the offering period or on the last trading day of the offering period.

 

Stock-Based Compensation Expense

 

Stock-based compensation expense was $4.9$4.4 million and $3.6$5.6 million for the three months ended June 30, 2021March 31, 2022 and 20202021, respectively, and $10.6 million and $6.7 million for the six months ended June 30, 2021 and 2020, respectively.

 

Stock Options

 

The following table summarizes stock option activity during the sixthree months ended June 30, 2021March 31, 2022:

 


 

    

Weighted-

     

Weighted-

 
    

Average

     

Average

 
 

Stock Options

  

Exercise Price

  

Stock Options

  

Exercise Price

 

Options outstanding at December 31, 2020

 229,531  $86.46 

Options outstanding at December 31, 2021

 233,384  $97.78 

Granted

 57,901 128.14  52,992 59.40 

Exercised

 (28,991) 58.78  (201) 30.58 

Forfeited

  (8,547) 101.65   (21,287) 86.55 

Options outstanding at June 30, 2021

  249,894  $98.81 

Options outstanding at March 31, 2022

  264,888  $91.06 
  

Exercisable at June 30, 2021

  116,452  $81.38 

Exercisable at March 31, 2022

  126,595  $87.42 

 


 

The outstanding options generally have a term of ten years. For employees, options granted become exercisable ratably over the vesting period, which is generally a period fromof four to five years, beginning on the first anniversary of the grant date, subject to the employee’s continuing service to the Company. For the board of directors, options generally become exercisable in full on the first anniversary of the grant date.

 

The weighted-average grant date fair value of options that were granted during the sixthree months ended June 30, 2021March 31, 2022 was $57.26.$27.84.

 

The following table provides the assumptions used in the Black-Scholes pricing model valuation of options during the sixthree months ended June 30, 2021March 31, 2022 and 20202021:

 


 

 

Six Months Ended June 30,

  

Three Months Ended March 31,

 
 

2021

  

2020

  

2022

  

2021

 

Risk-free interest rate

 0.80 - 1.12%  0.50 - 1.47%  

1.94%

  

0.80% - 0.96%

 

Expected life (years)

 6.25  6.25  6.25  6.25 

Expected volatility

 45.28 - 45.53%  42.40 - 43.83%  

45.95%

  

45.28 - 45.35%

 

Expected dividend yield

 0%  0%  

0%

  

0%

 

 


 

As of June 30, 2021March 31, 2022, there was $5.8$4.9 million of unrecognized compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 3.02.9 years.

 

11

Restricted Stock

 

Restricted stock awards are share-settled awards and restrictions lapse ratably over the vesting period, which is generally a period from three to five years, beginning on the first anniversary of the grant date, subject to the employee's continuing service to the Company. For the board of directors, restrictions generally lapse in full on the first anniversary of the grant date. 

 

The following table summarizes restricted stock activity during the sixthree months ended June 30, 2021March 31, 2022:

 


 

    

Weighted-

     

Weighted-

 
    

Average

     

Average

 
    

Grant Date

     

Grant Date

 
 

Restricted

 

Fair Value

  

Restricted

 

Fair Value

 
 

Stock

  

Per Share

  

Stock

  

Per Share

 

Restricted stock at December 31, 2020

 307,199  $98.87 

Restricted stock at December 31, 2021

 343,782  $111.79 

Granted

 178,398 133.67  44,782 59.40 

Restrictions lapsed

 (113,315) 91.10  (35,207) 123.15 

Forfeited

  (14,525) 105.72   (11,068) 109.73 

Restricted stock at June 30, 2021

  357,757  $118.41 

Restricted stock at March 31, 2022

  342,289  $103.84 

 


 

As of June 30, 2021March 31, 2022, there was $36.0$23.7 million of unrecognized compensation expense related to non-vested restricted stock, which is expected to be recognized over a weighted-average period of 2.82.5 years. 

 

12

Performance Stock

 

Performance stock units (PSUs) are expressed in terms of a target number of PSUs, with anywhere between 0 percent and 150200 percent of that target number capable of being earned and vesting at the end of a three-year performance period depending on the Company’s performance in the final year of the performance period and the award recipient’s continued employment. The Company’s PSUs granted from 2017 to 2019 and certain PSUs granted in 2021 are based on performance conditions and the related compensation cost is based on the probability that the performance conditions will be achieved. The Company’s PSUs granted in 2020 and 2022 and certain PSUs granted in 2021 are based on market conditions and the related compensation cost is based on the fair value at grant date calculated using a Monte Carlo pricing model.

 

The following table summarizes performance stock activity during the sixthree months ended June 30, 2021March 31, 2022:

 


 

    

Weighted-

     

Weighted-

 
    

Average

     

Average

 
    

Grant Date

     

Grant Date

 
 

Performance

 

Fair Value

  

Performance

 

Fair Value

 
 

Stock

  

Per Share

  

Stock

  

Per Share

 

Performance stock at December 31, 2020

 19,956  $118.66 

Performance stock at December 31, 2021

 16,839  $115.56 

Granted

 15,078 203.64  32,620 100.33 

Restrictions lapsed

 0  0  0  0 

Performance change

 0  0  0  0 

Forfeited

  (4,184) 99.59   0  0 

Performance stock at June 30, 2021

  30,850  $160.19 

Performance stock at March 31, 2022

  49,459  $105.52 

 


 

The following table provides the assumptions used in the Monte Carlo pricing model valuation of PSUs during the sixthree months ended June 30, 2021March 31, 2022 and 20202021

 


 

 

Six Months Ended June 30,

  

Three Months Ended March 31,

 
 

2021

  

2020

  

2022

  

2021

 

Risk-free interest rate

 0.22% 1.41% 

1.76%

  

0.22%

 

Expected life (years)

 2.87  2.88  2.87  2.87 

Expected volatility

 51.40% 38.70% 

53.50%

  

51.40%

 

Expected dividend yield

 0% 0% 

0%

  

0%

 

 


 

As of June 30, 2021March 31, 2022, there was $3.2$3.8 million of unrecognized compensation expense related to non-vested performance stock, which is expected to be recognized over a weighted-average period of 2.42.7 years. 

 

Employee Stock Purchase Plan

 

The following table presents the assumptions used to estimate the fair value of the ESPP during the sixthree months ended June 30, 2021March 31, 2022 and 20202021

 


 

 

Six Months Ended June 30,

  

Three Months Ended March 31,

 
 

2021

  

2020

  

2022

  

2021

 

Risk-free interest rate

 0.06 - 0.12%  0.17 - 1.59%  

0.17%

  

0.12%

 

Expected life (months)

 6.00  6.00  6.00  6.00 

Expected volatility

 50.85 - 65.53%  42.63 - 59.99%  

53.44%

  

50.85%

 

Expected dividend yield

 0%  0%  

0%

  

0%

 

 


 

13

 

 Note 1011 – Accumulated Other Comprehensive Income (Loss)

 

Other comprehensive income (loss) is comprised of foreign currency translation adjustments and net unrealized gains (losses) on investments in securities. The following table presents the changes in accumulated other comprehensive income (loss) balances during the three and sixmonths ended June 30, 2021March 31, 2022 and 20202021:

 


 

 

Three Months Ended

 

Six Months Ended

  

Three Months Ended

 
 

June 30,

  

June 30,

  

March 31,

 

(in thousands)

 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

 
          

Balance at beginning of period

 $(10,096) $(9,998) $(3,420) $(7,018) $(16,817) $(3,420)

Foreign currency translation adjustments

            

Other comprehensive income (loss) before reclassifications

 2,030 364 (4,812) (2,616)  (4,972)  (6,842)

Amounts reclassified from accumulated other comprehensive loss

  0   0   0   0   -   - 

Net current-period other comprehensive income (loss)

  2,030   364   (4,812)  (2,616)  (4,972)  (6,842)

Net unrealized gains (losses) on investments in securities

            

Other comprehensive income (loss) before reclassifications

 (49) 0 117 0   (516)  166 

Amounts reclassified from accumulated other comprehensive loss

  0   0   0   0   -   - 

Net current-period other comprehensive income (loss)

  (49)  0   117   0   (516)  166 

Balance at end of period

 $(8,115) $(9,634) $(8,115) $(9,634) $(22,305) $(10,096)

 


 

 

Note 1112 – Income Taxes

 

The Company is subject to income tax in multiple jurisdictions and the use of estimates is required to determine the provision for income taxes. For the three months ended June 30, 2021March 31, 2022 and 20202021, the Company recorded an income tax provision of $3.3$2.5 million and $2.5$0.2 million, respectively. The income tax provision is based on the estimated annual effective tax rate for the year applied to pre-tax income. The results for the three and six months ended June 30, 2021 reflect losses in jurisdictions that are not eligible for tax benefits on account of valuation allowances. The effective income tax rate for the three months ended June 30, 2021March 31, 2022 was 20.532.9 percent compared to 16.66.0 percent in the same period of the prior year. The effective tax rate increased by 3.926.9 percent for the three months ended June 30, 2021March 31, 2022 when compared to the same period in 20202021, primarily due to a decrease in tax benefits from the vesting of restricted stock and the exercise of stock options. The effective income tax rate for the six months ended June 30, 2021 was 17.6 percent compared to 19.4 percent in the same period of the prior year. The effective tax rate decreased by 1.8 percent for the six months ended June 30, 2021 when compared to the same period in 2020, primarily due to an increase in tax benefits from the vesting of restricted stock and the exercise of stock options.

 

The effective income tax rate for the sixthree months ended June 30, 2021March 31, 2022 differs from the U.S. federal statutory rate of 21.0 percent due to various factors, including operating in multiple state and foreign jurisdictions and tax credits for which the Company qualifies.

 

The Company had unrecognized tax benefits totaling $5.0$4.6 million as of June 30, 2021March 31, 2022 and $4.8$4.4 million as of December 31, 20202021, respectively, all of which,that if recognized would affectresult in a reduction of the Company’s effective tax rate. The liabilities are classified as other long-term liabilities in the accompanying consolidated balance sheets. The Company recognizes interest and penalties related to income tax matters in income tax expense and reports the liability in current or long-term income taxes payable as appropriate.

 

On March 11, 2021, the President signed into law the ARP Act, a legislative package which is generally not significant to the Company's current tax footprint; however, the Company will continue to assess the ARP Act on an ongoing basis. Similar tax provisions and other stimulus measures have been granted either before or after June 30, 2021 by certain foreign and U.S. state jurisdictions, which the Company continues to evaluate and apply, if applicable.

14

 

Note 1213 – Segment Reporting

 

The Company’s reportable segments are based on the internal reporting used by the Company’s Chief Executive Officer, who is the chief operating decision maker (CODM), to assess operating performance and make decisions about the allocation of resources. The Corporate Unallocated and Japan category includes non-reportable segments, as well as research and development and general and administrative costs that the Company does not allocate directly to its operating segments.

 

Intercompany transactions primarily relate to intercontinental activity and have been eliminated and are excluded from the reported amounts. The difference between income from operations and pre-tax income relates to foreign currency-related gains and losses and interest income on cash balances and investments, which are not allocated to business segments. 

 

Revenue and income from operations by reportable segment for the three and sixmonths ended June 30, 2021March 31, 2022 and 20202021 were as follows:

 


 

Three Months Ended June 30,

  

Six Months Ended June 30,

  

Three Months Ended March 31,

 

(in thousands)

 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

 

Revenue:

            

United States

 $95,344 $86,823 $186,397 $176,899  $95,496  $91,053 

Europe

 24,655 16,729 46,104 37,516  24,586  21,449 

Japan

  3,049   3,023   6,673   7,268   4,086   3,624 

Total revenue

 $123,048  $106,575  $239,174  $221,683  $124,168  $116,126 

 


 


 

 

Three Months Ended June 30,

  

Six Months Ended June 30,

  

Three Months Ended March 31,

 

(in thousands)

 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

 

Income from Operations:

        

Income (Loss) from Operations:

    

United States

 $26,280 $24,349 $48,783 $49,438  $22,524  $22,503 

Europe

 5,063 2,261 3,692 6,625  (1,679) (1,371)

Corporate Unallocated and Japan

  (15,239)  (12,259)  (32,110)  (24,887)  (12,955)  (16,871)

Total Income from Operations

 $16,104  $14,351  $20,365  $31,176  $7,890  $4,261 

 


 

Total long-lived assets at June 30, 2021March 31, 2022 and December 31, 20202021 were as follows:

 


 

 

June 30,

 

December 31,

  

March 31,

 

December 31,

 

(in thousands)

 

2021

  

2020

  2022  2021 

Total long-lived assets:

            

United States

 $222,117 $215,721  $209,416 $215,701 

Europe

 60,140 59,388  56,925 59,388 

Japan

  6,238   7,557   4,605   5,257 

Total Long-lived Assets

 $288,495  $282,666  $270,946  $280,346 

 


 

Revenue by product line for the three and sixmonths ended June 30, 2021March 31, 2022 and 20202021 were as follows:

 


 

 

Three Months Ended June 30,

  

Six Months Ended June 30,

  

Three Months Ended March 31,

 

(in thousands)

 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

 

Revenue:

            

Injection Molding

 $58,168 $57,894 $114,527 $112,670  $53,398  $56,359 

CNC Machining

 41,592 28,760 78,295 66,645  46,098  36,703 

3D Printing

 18,170 14,236 35,405 30,184  19,672  17,235 

Sheet Metal

 4,717 4,669 9,936 10,318  4,687  5,219 

Other Revenue

  401   1,016   1,011   1,866   313   610 

Total revenue

 $123,048  $106,575  $239,174  $221,683  $124,168  $116,126 

 


 

15

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2020.2021.

 

Forward-Looking Statements

 

Statements contained in this report regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve known and unknown risks, uncertainties and other factors that may cause our results to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in Item 1A. “Risk Factors” of this Form 10-Q, as well as our most recent Annual Report on Form 10-K as filed with the Securities and Exchange Commission (SEC). Other unknown or unpredictable factors also could have material adverse effects on our future results. We cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, we expressly disclaim any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

 

Overview

 

We are one of the world’s largest and fastest digital manufacturer of custom prototypes and on-demand production parts. Our mission is to empower companies to bring new ideas to market by offering the fastest and most comprehensive digital manufacturing service in the world. Our automated quoting and manufacturing systems allow us to produce commercial-grade plastic, metal, and liquid silicone rubber parts in as fast as one day. We manufacture prototypesprototype and low-volumelow volume production parts for companies worldwide, who are under increasing pressure to bring their finished products to market faster than their competition. We utilize injection molding, computer numerical control (CNC) machining, 3D printing and sheet metal fabrication to manufacture custom parts for our customers. OurFor most of our offerings, our proprietary technology eliminates most of the time-consuming and expensive skilled labor conventionally required to quote and manufacture parts. In January 2021, we acquired Hubs, a leading online manufacturing platform based in Amsterdam, Netherlands, that provides customers with on-demand access to a global network of premium manufacturing partners. This acquisition creates the world's largest digital manufacturing platform, offering the broadest set of manufacturing services with the help of a global network of premium manufacturing providers. Our customers conduct nearly all of their business with us over the Internet. We target our products to the millions of product developers and engineers who use three-dimensional computer-aided design (3D CAD) software to design products across a diverse range of end-markets. In addition, we serve procurement and supply chain professionals seeking to manufacture custom parts on-demand. Through the acquisition of Hubs (formerly 3D Hubs, Inc.) (Hubs) in 2021, we are able to provide our customers access to a global network of premium manufacturing partners who reside across North America, Europe and Asia, complementing our in-house manufacturing. We believe our use of advanced technology enables us to offer significant advantages at competitive prices to many customers and is the primary reason we have become a leading supplier of custom parts.

 

Our primary manufacturing product lines currently include Injection Molding, CNC Machining, 3D Printing and Sheet Metal. We continually seek to expand the range of sizes and geometric complexity of the parts we can make with these processes, to extend the variety of materials we are able to support, and to identify additional manufacturing processes to which we can apply our technology in order to better serve the evolving preferences and needs of product developers and engineers. TheIn 2021, we augmented our internal manufacturing operations through our acquisition of Hubs broadensto expand the envelope of custom parts we can provide to our offer beyond our current manufacturing capabilities and provides a broader range of price and lead time options by leveragingcustomers through a network of premium manufacturing partners to meet the holistic needsin each of our customers.product lines.

Injection Molding

 

Our Injection Molding product line uses our 3D CAD-to-CNC machining technology for the automated design and manufacture of molds, which are then used to produce custom plastic and liquid silicone rubber injection-molded parts and over-molded and insert-molded injection-molded parts on commercially available equipment. Our Injection Molding product line works best for on-demand production, bridge tooling, pilot runs and functional prototyping. Our affordable aluminum molds and quick turnaround times help reduce design risk and limit overall production costs for product developers and engineers. Because we retain possession of the molds, customers who need short-run production often come back to Protolabs’Proto Labs’ Injection Molding product line for additional quantities. They do so to support pilot production for product testing, while their tooling for high-volume production is being prepared, because they need on-demand manufacturing due to disruptions in their manufacturing process, because their product requires limited annual quantity or because they need end-of-life production support. In 2017, we launched an on-demand manufacturing injection molding product offering.service. This service utilizes our existing processes, but is designed to fulfill the needs of customers with on-going production needs.

 

CNC Machining

 

Our CNC Machining product line uses commercially available CNC machines to offer milling and turning. CNC milling is a manufacturing process that cuts plastic and metal blocks into one or more custom parts based on the 3D CAD model uploaded by the product developer or engineer.customer. CNC turning with live tooling combines both lathe and mill capabilities to machine parts with cylindrical features fromis a subtractive manufacturing process that rotates a metal rod stock. Our efficiencies derive from the automation of the programming of these machineswhile a cutting tool is used to remove material and a proprietary fixturing process.

create final parts. Quick-turn CNC machining works best for prototyping, form and fit testing, jigs and fixtures and functional components for end-use applications.

 

16

 

Industrial 3D Printing

 

Our Industrial 3D Printing product line includes stereolithography, selective laser sintering, direct metal laser sintering, Multi Jet Fusion,SL, SLS, DMLS, MJF, PolyJet, Carbon DLS and digital light synthesisfused deposition modeling (FDM) processes, which offeroffers customers a wide-variety of high-quality, precision rapid prototyping and low-volumelow volume production. These processes create parts with a high level of accuracy, detail, strength and durability. Industrial 3D Printing is best suited for functional prototypes, complex designs and end-use applications.

 

Sheet Metal

 

Our Sheet Metal product line includes quick-turn and e-commerce-enabled custom sheet metal parts, which providesproviding customers with prototype and low-volume production parts. The rapid prototype sheet metal process is most often used when form, fit and function are all a priority. Our manufacturing process uses customer 3D CAD models uploaded by the product developer or engineercustomer to fabricate quick-turn prototyperapid prototyping sheet metal or short-runend-use production parts.parts and assemblies.

 

Key Financial Measures and Trends

 

Revenue

 

Our operations are comprised of three geographic operating segments in the United States, Europe and Japan. Revenue is derived from our Injection Molding, CNC Machining, 3D Printing and Sheet Metal product lines. Injection Molding revenue consists of sales of custom injection molds and injection-molded parts. CNC Machining revenue consists of sales of CNC-machined custom parts. 3D Printing revenue consists of sales of 3D-printed parts. Sheet Metal revenue consists of sales of fabricated sheet metal custom parts. Our historical and current efforts to increase revenue have been directed at expanding the breadth of our product offerings, gaining new customers and selling to our existing customer base by increasing marketing and selling activities, including:

 

 

expanding the breadth and scope of each of our product linesproducts by adding more sizes and materials to our offerings;

 

 

 

 

the introduction of our 3D Printing product line through our acquisition of FineLine in 2014;

 

 

 

 

expanding 3D Printing to Europe through our acquisition of Alphaform in October 2015;

 

 

 

 

the introduction of our Sheet Metal product line through our acquisition of Rapid Manufacturing Group, LLC (RAPID) in 20172017;

 

 

 

 

continuously improving the usability of our product lines such as our web-centric applications; and

   
 providing customers with on-demand access to a global network of premium manufacturing partners through our acquisition of Hubs in January 2021.

 

During the three months ended June 30, 2021,March 31, 2022, we served 23,25323,492 unique product developers and engineers who purchased our products through our web-based customer interface, an increase of 36.5%3.9% over the same period in 2020. The increase in product developers was driven primarily by our acquisition of Hubs. Excluding the impact of Hubs, our product developers increased 14.3% during the three months ended June 30, 2021 when compared to the same period in 2020. During the six months ended June 30, 2021, we served 37,501 unique product developers and engineers who purchased our products through our web-based customer interface, an increase of 26.3% over the same period in 2020. The increase in unique product developers served was driven primarily by our acquisition of Hubs. Excluding the impact of Hubs, unique product developers served increased 7.1% during the six months ended June 30, 2021 when compared to the same period in 2020. The economic uncertainty arising from the COVID-19 pandemic has impacted the number of product developers and engineers who purchase our products. While we expect the number of product developers and engineers served to grow in the long-term, challenges posed by the COVID-19 pandemic on the global economy have continued through the date of this report. At this time, it is difficult to predict the future given the current economic uncertainty and evolving market conditions.2021. 

 

Cost of Revenue, Gross Profit and Gross Margin

 

Cost of revenue consists primarily of raw materials, equipment depreciation, employee compensation, benefits, stock-based compensation, facilities costs and overhead allocations and outsourced manufacturing costs associated with the manufacturing process for molds and customcustomer parts. We expect our personnel-related costs to increase in order to retain and attract top talent and remain competitive in the market. Overall, we expect cost of revenue to increase in absolute dollars.

 

We define gross profit as our revenue less our cost of revenue, and we define gross margin as gross profit expressed as a percentage of revenue. We expect our gross profit to increase in absolute dollars, however our gross margin may fluctuate based on the business mix in each reporting period. Our gross profit and gross margin are affected by many factors, including our mix of revenue by product line, pricing, sales volume, manufacturing costs, the costs associated with increasing production capacity, the mix between domestic and foreign revenue sources, the mix between revenue produced in our internal manufacturing operations and outsourced to our external manufacturing partners, and foreign exchange rates.

 

17

 

Operating Expenses

 

Operating expenses consist of marketing and sales, research and development and general and administrative expenses. Personnel-related costs are the most significant component in each of these categories.

 

Our recent growth in operating expenses is mainly due to theThe launch of our Protolabs 2.0 project, an internal business systems initiative impacting both external customer-facing and internal back-end systems, in the fourthUnited States in the first quarter of 2020. During2021, and our acquisition of Hubs in January 2021, led to higher operating expenses in the developmentfirst quarter of Protolabs 2.0, certain research and development personnel costs were capitalizable as a software development asset. Since the system was placed in service in November 2020, the personnel costs have been expensed as incurred. In addition, amortization expense for the software asset is now being recorded over the systems’ estimated useful lives of seven to 10 years.2021. Our business strategy is to continue to be a leading online and technology-enabled manufacturer of quick-turn, on-demand injection-molded, CNC-machined, CNC-turned, 3D-printed and sheet metal custom parts for prototyping and low-volume production. In order to achieve our goals, we anticipate continued substantial investments in technology and personnel, resulting in increased operating expenses.expenses in the future.

 

Marketing and sales. Marketing and sales expense consists primarily of employee compensation, benefits, commissions, stock-based compensation, marketing programs such as electronic, print and pay-per-click advertising, trade shows and other related overhead, which includes an allocation of information technology expense including amortization of Protolabs 2.0 software assets. We expect sales and marketing expense to increase in the future as we increase the number of marketing and sales professionals and marketing programs targeted to increase our customer base and grow revenue.

 

Research and development. Research and development expense consists primarily of personnel and outside service costs related to the development of new processes and product lines, enhancement of existing product lines, development of software for internal use, maintenance of internally developed software, quality assurance and testing. Costs for internal use software are evaluated by project and capitalized where appropriate under ASC 350-40, Intangibles — Goodwill and Other, Internal-Use Software. We expect research and development expense to increase in the future as we seek to enhance our e-commerce interface technology, internal software and supporting business systems, and continue to expand our product lines.

 

General and administrative. General and administrative expense consists primarily of employee compensation, benefits, stock-based compensation, professional service fees related to accounting, tax and legal, and other related overhead, which includes an allocation of information technology expense including amortization of Protolabs 2.0 software assets. We expect general and administrative expense to increase in the future as we continue to grow and expand as a global organization.

 

Other Income,Loss, net

 

Other income,loss, net primarily consists of foreign currency-related gains and losses and interest income on cash balances and investments. Our foreign currency-related gains and losses will vary depending upon movements in underlying exchange rates. Our interest income will vary each reporting period depending on our average cash balances during the period, composition of our marketable security portfolio and the current level of interest rates.

 

Provision for Income Taxes

 

Provision for income taxes is comprised of federal, state, local and foreign taxes based on pre-tax income. Overall, we expect our effective tax rate for 20212022 and beyond will remain consistent basedmay differ from historical effective tax rates due to increases in losses in foreign operations that are not eligible for tax benefits on the currentaccount of valuation allowances, as well as any future tax laws.law changes that may impact our effective tax rate.

 

18

 

Results of Operations

 

The following table summarizes our results of operations and the related changes for the periods indicated. The results below are not necessarily indicative of the results for future periods. 

 


 

  

Three Months Ended June 30,

  

Change

  

Six Months Ended June 30,

  

Change

 

(dollars in thousands)

 

2021

  

2020

  

$

  

%

  

2021

  

2020

  

$

  

%

 

Revenue

 $123,048   100.0  $106,575   100.0  $16,473   15.5  $239,174   100.0  $221,683   100.0  $17,491   7.9 

Cost of revenue

  66,423   54.0   54,119   50.8   12,304   22.7   127,219   53.2   111,127   50.1   16,092   14.5 

Gross profit

  56,625   46.0   52,456   49.2   4,169   7.9   111,955   46.8   110,556   49.9   1,399   1.3 

Operating expenses:

                                                

Marketing and sales

  21,044   17.1   16,936   15.9   4,108   24.3   40,524   16.9   35,116   15.8   5,408   15.4 

Research and development

  11,060   9.0   8,648   8.1   2,412   27.9   23,241   9.7   17,635   8.0   5,606   31.8 

General and administrative

  16,180   13.1   12,521   11.7   3,659   29.2   35,588   14.9   26,629   12.0   8,959   33.6 

Changes in fair value of contingent consideration

  (7,763)  (6.3)  -   -   (7,763)  *   (7,763)  (3.2)  -   -   (7,763)  * 

Total operating expenses

  40,521   32.9   38,105   35.8   2,416   6.3   91,590   38.3   79,380   35.8   12,210   15.4 

Income from operations

  16,104   13.1   14,351   13.5   1,753   12.2   20,365   8.5   31,176   14.1   (10,811)  (34.7)

Other income (loss), net

  137   0.1   767   0.7   (630)  (82.1)  (176)  (0.1)  1,821   0.8   (1,997)  (109.7)

Income before income taxes

  16,241   13.2   15,118   14.2   1,123   7.4   20,189   8.4   32,997   14.9   (12,808)  (38.8)

Provision for income taxes

  3,326   2.7   2,511   2.4   815   32.5   3,562   1.5   6,406   2.9   (2,844)  (44.4)

Net income

 $12,915   10.5% $12,607   11.8% $308   2.4% $16,627   7.0% $26,591   12.0% $(9,964)  (37.5)%


*Percentage change not meaningful

  

Three Months Ended March 31,

  

Change

 

(dollars in thousands)

 

2022

  

2021

  

$

  

%

 

Revenue

 $124,168   100.0  $116,126   100.0  $8,042   6.9 

Cost of revenue

  68,364   55.1   60,796   52.4   7,568   12.4 

Gross profit

  55,804   44.9   55,330   47.6   474   0.9 

Operating expenses:

                        

Marketing and sales

  20,586   16.6   19,480   16.8   1,106   5.7 

Research and development

  10,557   8.5   12,181   10.5   (1,624)  (13.3)

General and administrative

  16,771   13.5   19,408   16.7   (2,637)  (13.6)

Total operating expenses

  47,914   38.6   51,069   44.0   (3,155)  (6.2)

Income from operations

  7,890   6.3   4,261   3.7   3,629   85.2 

Other loss, net

  (300)  (0.2)  (313)  (0.3)  13   (4.2)

Income before income taxes

  7,590   6.1   3,948   3.4   3,642   92.2 

Provision for income taxes

  2,495   2.0   236   0.2   2,259   957.2 

Net income

 $5,095   4.1% $3,712   3.2% $1,383   37.3%

 

Stock-based compensation expense included in the statements of operations data above for the three and six months ended June 30,March 31, 2022 and 2021 and 2020 waswere as follows:

 


 

 

Three Months Ended June 30,

  

Six Months Ended June 30,

  

Three Months Ended March 31,

 

(dollars in thousands)

 

2021

  

2020

  

2021

  

2020

  

2022

  

2021

 

Stock options and restricted stock

 $4,563 $3,331 $9,854 $6,069 

Stock options, restricted stock and performance stock

 $4,006  $5,291 

Employee stock purchase plan

  378   308   707   603   391   329 

Total stock-based compensation expense

 $4,941  $3,639  $10,561  $6,672  $4,397  $5,620 
  

Cost of revenue

 $668 $594 $1,303 $1,115  $587  $635 

Operating expenses:

  

Marketing and sales

 929 750 1,782 1,368  737  853 

Research and development

 744 607 1,368 1,128  629  624 

General and administrative

  2,600   1,688   6,108   3,061   2,444   3,508 

Total stock-based compensation expense

 $4,941  $3,639  $10,561  $6,672  $4,397  $5,620 

 


 

19

 

Comparison of Three Months Ended June 30,March 31, 2022 and 2021 and 2020

 

Revenue

 

Revenue by reportable segment and the related changes for the three months ended June 30,March 31, 2022 and 2021 and 2020 were as follows:

 


 

 

Three Months Ended June 30,

        

Three Months Ended March 31,

       
 

2021

  

2020

  

Change

  

2022

  

2021

  

Change

 

(dollars in thousands)

 

$

  

% of Total Revenue

  

$

  

% of Total Revenue

  

$

  

%

  

$

  

% of Total Revenue

  

$

  

% of Total Revenue

  

$

  

%

 

Revenue

                          

United States

 $95,344  77.5% $86,823  81.5% $8,521  9.8% $95,496  76.9% $91,053  78.4% $4,443  4.9%

Europe

 24,655  20.0  16,729  15.7  7,926  47.4  24,586  19.8  21,449  18.5  3,137  14.6 

Japan

  3,049   2.5   3,023   2.8   26   0.9   4,086   3.3   3,624   3.1   462   12.7 

Total revenue

 $123,048   100.0% $106,575   100.0% $16,473   15.5% $124,168   100.0% $116,126   100.0% $8,042   6.9%

 


 

Our revenue increased $16.5$8.0 million, or 15.5%6.9%, for the three months ended June 30, 2021March 31, 2022 compared to the same period in 2020. Our revenue for the three months ended June 30, 2021 includes revenue of $8.9 million provided by our acquisition of Hubs.2021. By reportable segment, revenue in the United States increased $8.5$4.4 million, or 9.8%4.9%, for the three months ended June 30, 2021March 31, 2022 compared to the same period in 2020.2021. Revenue in Europe increased $7.9$3.1 million, or 47.4%14.6%, and revenue in Japan increased 0.9%$0.5 million, or 12.7%, in each case for the three months ended June 30, 2021March 31, 2022 compared to the same period in 2020. Excluding2021. Our acquisition of Hubs provided revenue of $4.8 million and $3.2 million in the United States increased $3.9and $5.5 million or 4.5%, and revenue$2.6 million in Europe increased $3.6 million, or 21.6%, infor each case forof the three months ended June 30,March 31, 2022 and 2021, respectively. Hubs revenue in 2021 represents the period from January 22, 2021, the date of acquisition, through March 31, 2021. International revenue was negatively impacted by $1.5 million during the three months ended March 31, 2022 compared to the same period in 2020. International revenue was positively impacted by $1.9 million during the three months ended June 30, 2021 compared to the same period in 2020 as a result of foreign currency movements, primarily the strengtheningweakening of the British Pound and Euro relative to the United States Dollar.

 

During the three months ended June 30, 2021,March 31, 2022, we served 23,25323,492 unique product developers and engineers, an increase of 36.5%3.9% over the same period in 2020. The increase2021. Our growth in unique product developers served was primarily driven by our acquisition of Hubs. Excluding the impact of Hubs, unique product developers served increased 14.3% during the three months ended June 30, 2021 when compared to the same period in 2020. The economic uncertainty arising from the COVID-19 pandemic has impacted the number of product developers and engineers who purchase our products. While we expect the number of product developers and engineers served to growincreased at a lower rate than our revenue growth, resulting in an increase in the long-term, challenges posedaverage spend per product developer and engineer. The increase in average spend per product developer and engineer was driven by price increases and a change in the COVID-19 pandemic onmix of products with a higher average order size purchased during the global economy have continued through the date of this report. At this time, it is difficult to predict the future given the current economic uncertaintyquarter by product developers and evolving market conditions.engineers we serve.

 

Revenue by product line and the related changes for the three months ended June 30,March 31, 2022 and 2021 and 2020 were as follows:

 


 

 

Three Months Ended June 30,

        

Three Months Ended March 31,

       
 

2021

  

2020

  

Change

  

2022

  

2021

  

Change

 

(dollars in thousands)

 

$

  

% of Total Revenue

  

$

  

% of Total Revenue

  

$

  

%

  

$

  

% of Total Revenue

  

$

  

% of Total Revenue

  

$

  

%

 

Revenue

                          

Injection Molding

 $58,168 47.3% $57,894 54.3% $274 0.5% $53,398 43.0% $56,359 48.5% $(2,961) (5.3)%

CNC Machining

 41,592 33.8 28,760 27.0 12,832 44.6  46,098 37.1 36,703 31.6 9,395 25.6 

3D Printing

 18,170 14.8 14,236 13.4 3,934 27.6  19,672 15.8 17,235 14.8 2,437 14.1 

Sheet Metal

 4,717 3.8 4,669 4.4 48 1.0  4,687 3.8 5,219 4.5 (532) (10.2)

Other Revenue

  401   0.3   1,016   1.0   (615)  (60.5)  313   0.3   610   0.5   (297)  (48.7)

Total revenue

 $123,048   100.0% $106,575   100.0% $16,473   15.5% $124,168   100.0% $116,126   100.0% $8,042   6.9%

 


 

By product line, our revenue increase was driven by a 44.6%25.6% increase in CNC Machining revenue and a 27.6%14.1% increase in 3D Printing revenue, a 0.5% increase in Injection Molding revenue and a 1.0% increase in Sheet Metal revenue, which was partially offset by a 60.5%5.3% decrease in Injection Molding revenue, a 10.2% decrease in Sheet Metal revenue and a 48.7% decrease in Other Revenue, in each case for the three months ended June 30, 2021March 31, 2022 compared to the same period in 2020.2021.

 

20

 

Cost of Revenue, Gross Profit and Gross Margin

 

Cost of Revenue. Cost of revenue increased $12.3$7.6 million, or 22.7%12.4%, for the three months ended June 30, 2021March 31, 2022 compared to the same period in 2020,2021, which was greater than the rate of revenue increase of 15.5%6.9% for the three months ended June 30, 2021March 31, 2022 compared to the same period in 2020.2021. The increase in cost of revenue was driven by a $7.8 million increase resulting from our acquisition of Hubs. The $4.5$4.9 million increase in cost of revenue in our legacy business was driven by an increaseincreased volumes and a labor shortage resulting in headcount resulting inwage inflation driving personnel and related cost increases of $2.6$2.5 million, an increase in raw material and product costs of $1.5$2.1 million driven by materials cost inflation and higher logistics costs, and an increase in equipment and facility related costs of $0.4$0.3 million. Our acquisition of Hubs provided a $2.7 million increase in cost of revenue for the three months ended March 31, 2022 when compared to the same period in 2021.

 

Gross Profit and Gross Margin. Gross profit increased from $52.5$55.3 million in the three months ended June 30, 2020March 31, 2021 to $56.6$55.8 million in the three months ended June 30, 2021.March 31, 2022. Gross margin decreased from 49.2%47.6% in the three months ended June 30, 2020March 31, 2021 to 46.0%44.9% in the three months ended June 30, 2021,March 31, 2022, primarily due to labor and materials cost inflation and the mix of revenue.

 

Operating Expenses, Other Income, net and Provision for Income Taxes

 

Marketing and Sales. Marketing and sales expenses increased $4.1$1.1 million, or 24.3%5.7%, during the three months ended June 30, 2021March 31, 2022 compared to the same period in 2020.2021. The increase is primarily driven by personnel and related cost increases in our legacy business of $1.2 million, information technology allocation cost increases, including amortization of Protolabs 2.0 software assets, of $1.2$0.3 million and marketing program cost increases of $0.4$0.3 million, which were partially offset by personnel and related cost decreases in our legacy business of $0.2 million. In addition, our acquisition of Hubs provided $1.3a $0.7 million increase in marketing and sales expenses during the three months ended June 30,March 31, 2022 when compared to the same period in 2021.

 

Research and Development. Our research and development expenses increased $2.4decreased $1.6 million, or 27.9%13.3%, during the three months ended June 30, 2021March 31, 2022 compared to the same period in 20202021 primarily due to personnel and related cost increasesdecreases of $1.6$2.2 million driven by personnel and contractor resources dedicated to the launch of our Protolabs 2.0 system. Duringsystem in the developmentfirst quarter of Protolabs 2.0, certain2021. Other legacy operating costs increased $0.1 million during the three months ended March 31, 2022. In addition, our acquisition of Hubs provided a $0.5 million increase in research and development personnel costs were capitalizable as a software development asset. Sinceexpenses during the system was placedthree months ended March 31, 2022 when compared to the same period in service in November 2020, the personnel costs have been expensed as incurred. In addition, increases of $0.8 million resulted from our acquisition of Hubs.2021.

 

General and Administrative. Our general and administrative expenses increased $3.7decreased $2.6 million, or 29.2%13.6%, during the three months ended June 30, 2021March 31, 2022 compared to the same period in 20202021 primarily due to an increasea decrease of $0.6$2.4 million in professional service costs an increaseprimarily driven by increased transaction costs in 2021 related to our acquisition of $0.2 millionHubs and a decrease of personnel and related costs and an increase of $0.2$1.3 million in administrative costs.stock-based compensation expense primarily driven by increased stock-based compensation expense in 2021 related to the retirement of our CEO. In addition, our acquisition of Hubs provided $2.7an increase of $1.1 million in general and administrative expense during the three months ended June 30, 2021.

Changes in fair value of contingent consideration. The fair value of contingent consideration associated with the acquisition of Hubs decreased $7.8 million during the three months ended June 30, 2021March 31, 2022 when compared to the same period in 2020. We had no contingent consideration liabilities recorded during the three months ended June 30, 2020.2021.

  

Other Income,Loss, net. We recognized other income,loss, net of $0.1$0.3 million for the three months ended June 30, 2021, a decrease of $0.7 million compared toMarch 31, 2022, consistent with other income,loss, net of $0.8$0.3 million for the three months ended June 30, 2020.March 31, 2021. Other income,loss, net for the three months ended June 30, 2021March 31, 2022 primarily consisted of a gain$0.3 million loss on foreign currency and interest income on investments.currency. Other income,loss, net for the three months ended June 30, 2020March 31, 2021 primarily consisted of $0.4a $0.5 million loss on foreign currency, which was partially offset by $0.1 million in interest income on investments and a $0.3$0.1 million gain on foreign currency.in other income.

 

Provision for Income Taxes. Our effective tax rate of 20.5%32.9% for the three months ended June 30, 2021March 31, 2022 increased 3.9%26.9% compared to 16.6%6.0% for the same period in 2020.2021. The increase in the effective tax rate is primarily due to a decrease in tax benefits from the vesting of restricted stock and the exercise of stock options. Our income tax provision of $3.3$2.5 million for the three months ended June 30, 2021March 31, 2022 increased $0.8$2.3 million compared to our income tax provision of $2.5$0.2 million for the three months ended June 30, 2020, due to a combination of higher pre-tax income and a higher effective tax rate.March 31, 2021.

 

21

Comparison of Six Months Ended June 30, 2021 and 2020

Revenue

Revenue by reportable segment and the related changes for the six months ended June 30, 2021 and 2020 were as follows:


  

Six Months Ended June 30,

         
  

2021

  

2020

  

Change

 

(dollars in thousands)

 

$

  

% of Total Revenue

  

$

  

% of Total Revenue

  

$

  

%

 

Revenue

                        

United States

 $186,397   78.0% $176,899   79.8% $9,498   5.4%

Europe

  46,104   19.3   37,516   16.9   8,588   22.9 

Japan

  6,673   2.8   7,268   3.3   (595)  (8.2)

Total revenue

 $239,174   100.0% $221,683   100.0% $17,491   7.9%


Our revenue increased $17.5 million, or 7.9%, for the six months ended June 30, 2021 compared to the same period in 2020. Our revenue for the six months ended June 30, 2021 includes revenue of $14.7 million provided by our acquisition of Hubs. By reportable segment, revenue in the United States increased $9.5 million, or 5.4%, for the six months ended June 30, 2021 compared to the same period in 2020. Revenue in Europe increased $8.6 million, or 22.9% and revenue in Japan decreased $0.6 million, or 8.2%, in each case for the six months ended June 30, 2021 compared to the same period in 2020. Excluding Hubs, revenue in the United States increased $1.7 million, or 1.0%, and revenue in Europe increased $1.7 million, or 4.4%, in each case for the six months ended June 30, 2021 compared to the same period in 2020. International revenue was positively impacted by $3.5 million during the six months ended June 30, 2021 compared to the same period in 2020 as a result of foreign currency movements, primarily the strengthening of the British Pound and Euro relative to the United States Dollar.

During the six months ended June 30, 2021, we served 37,501 unique product developers and engineers, an increase of 26.3% over the same period in 2020. The increase in unique product developers served was primarily driven by our acquisition of Hubs. Excluding the impact of Hubs, unique product developers served increased 7.1% during the six months ended June 30, 2021 when compared to the same period in 2020. The economic uncertainty arising from the COVID-19 pandemic has impacted the number of product developers and engineers who purchase our products. While we expect the number of product developers and engineers served to grow in the long-term, challenges posed by the COVID-19 pandemic on the global economy have continued through the date of this report. At this time, it is difficult to predict the future given the current economic uncertainty and evolving market conditions.

Revenue by product line and the related changes for the six months ended June 30, 2021 and 2020 were as follows:


  

Six Months Ended June 30,

         
  

2021

  

2020

  

Change

 

(dollars in thousands)

 

$

  

% of Total Revenue

  

$

  

% of Total Revenue

  

$

  

%

 

Revenue

                        

Injection Molding

 $114,527   47.9% $112,670   50.8% $1,857   1.6%

CNC Machining

  78,295   32.7   66,645   30.1   11,650   17.5 

3D Printing

  35,405   14.8   30,184   13.6   5,221   17.3 

Sheet Metal

  9,936   4.2   10,318   4.7   (382)  (3.7)

Other Revenue

  1,011   0.4   1,866   0.8   (855)  (45.8)

Total revenue

 $239,174   100.0% $221,683   100.0% $17,491   7.9%


By product line, our revenue increase was driven by a 17.5% increase in CNC Machining revenue, a 17.3% increase in 3D Printing revenue, and a 1.6% increase in Injection Molding revenue, which was partially offset by a 3.7% decrease in Sheet Metal revenue, and a 45.8% decrease in Other Revenue, in each case for the six months ended June 30, 2021 compared to the same period in 2020.

22

Cost of Revenue, Gross Profit and Gross Margin

Cost of Revenue. Cost of revenue increased $16.1 million, or 14.5%, for the six months ended June 30, 2021 compared to the same period in 2020, which was greater than the rate of revenue increase of 7.9% for the six months ended June 30, 2021 compared to the same period in 2020. The increase in cost of revenue was driven by a $12.9 million increase resulting from our acquisition of Hubs. In our legacy business, cost of revenue increased $3.2 million due to an increase in headcount resulting in personnel and related cost increases of $1.7 million, an increase in raw material and product costs of $1.0 million, and an increase in equipment and facility related costs of $0.5 million.

Gross Profit and Gross Margin. Gross profit increased from $110.6 million in the six months ended June 30, 2020 to $112.0 million in the six months ended June 30, 2021. Gross margin decreased from 49.9% in the six months ended June 30, 2020 to 46.8% in the six months ended June 30, 2021, primarily due to the mix of revenue.

Operating Expenses, Other (Loss) Income, net and Provision for Income Taxes

Marketing and Sales. Marketing and sales expenses increased $5.4 million, or 15.4%, during the six months ended June 30, 2021 compared to the same period in 2020. In our legacy business, personnel and related cost increases of $1.2 million and information technology allocation cost increases, including amortization of Protolabs 2.0 software assets, of $2.2 million were partially offset by marketing program cost decreases of $0.3 million. In addition, our acquisition of Hubs provided $2.3 million in marketing and sales expense during the six months ended June 30, 2021.

Research and Development. Our research and development expenses increased $5.6 million, or 31.8%, during the six months ended June 30, 2021 compared to the same period in 2020 primarily due to personnel and related cost increases of $4.4 million driven by personnel and contractor resources dedicated to the launch of our Protolabs 2.0 system. During the development of Protolabs 2.0, certain research and development personnel costs were capitalizable as a software development asset. Since the system was placed in service in November 2020, the personnel costs have been expensed as incurred. In addition, increases of $1.3 million resulted from our acquisition of Hubs, which were partially offset by decreases of $0.1 in professional service costs.

General and Administrative. Our general and administrative expenses increased $9.0 million, or 33.6%, during the six months ended June 30, 2021 compared to the same period in 2020 primarily due to an increase of $4.8 million resulting from our acquisition of Hubs, other professional service cost increases of $3.4 million and stock-based compensation cost increases of $1.7 million, which were partially offset by administrative cost decreases of $0.7 million and personnel and related cost decreases of $0.2 million.

Changes in fair value of contingent consideration. The fair value of contingent consideration associated with the acquisition of Hubs decreased $7.8 million during the six months ended June 30, 2021. We had no contingent consideration liabilities recorded during the six months ended June 30, 2020.

Other (Loss) Income, net. We recognized other loss, net of $0.2 million for the six months ended June 30, 2021, a decrease of $2.0 million compared to other income, net of $1.8 million for the six months ended June 30, 2020. Other loss, net for the six months ended June 30, 2021 primarily consisted of a $0.5 million loss on foreign currency, which was partially offset by $0.2 million in interest income on investments and $0.1 million in other income. Other income, net for the six months ended June 30, 2020 primarily consisted of $0.9 million in interest income on investments and a $0.9 million gain on foreign currency.

Provision for Income Taxes. Our effective tax rate of 17.6% for the six months ended June 30, 2021 decreased 1.8% compared to 19.4% for the same period in 2020. The decrease in the effective tax rate is primarily due to an increase in tax benefits from the vesting of restricted stock and the exercise of stock options. Our income tax provision of $3.6 million for the six months ended June 30, 2021 decreased $2.8 million compared to our income tax provision of $6.4 million for the six months ended June 30, 2020, due to a combination of lower pre-tax income and the lower effective tax rate.

23

 

Liquidity and Capital Resources

 

Cash Flows

 

The following table summarizes our cash flows during the sixthree months ended June 30, 2021March 31, 2022 and 2020:2021:

 


 

 

Six Months Ended June 30,

  

Three Months Ended March 31,

 

(dollars in thousands)

 

2021

  

2020

  2022  2021 

Net cash provided by operating activities

 $20,729  $53,417  $17,783  $6,425 

Net cash used in investing activities

 (105,082) (65,292) (25,835) (90,133)

Net cash used in financing activities

 (1,856) (15,198) (601) (427)

Effect of exchange rates on cash and cash equivalents

  515   (149)  (37)  306 

Net decrease in cash and cash equivalents

 $(85,694) $(27,222) $(8,690) $(83,829)

 


 

Sources of Liquidity

 

Historically, we have primarily financed our operations and capital expenditures through cash flow from operations. We had cash and cash equivalents of $41.9$57.2 million as of June 30, 2021,March 31, 2022, a decrease of $85.7$8.7 million from December 31, 2020.2021. The decrease in our cash was primarily due to cash used in investing activity for our acquisitionpurchases of Hubsmarketable securities, net of $127.4$22.8 million, and purchases of property, equipment and other capital assets of $23.9$3.1 million, and cash used in financing activities of $0.6 million, which were partially offset by net proceeds from investments in marketable securities of $46.2 million and cash generated through operations of $20.7$17.8 million.

 

Cash Flows from Operating Activities

 

Cash flows from operating activities were $20.7$17.8 million during the sixthree months ended June 30, 2021March 31, 2022 and primarily consisted of net income of $16.6$5.1 million, adjusted for certain non-cash items, including depreciation and amortization of $20.1$10.2 million and stock-based compensation expense of $10.6 million, which were partially offset by a decrease in the fair value of contingent consideration of $7.8 million and changes in operating assets and liabilities and other items totaling $18.8 million. Cash flows from operating activities were $53.4 million during the six months ended June 30, 2020 and primarily consisted of net income of $26.6 million, adjusted for certain non-cash items, including depreciation and amortization of $15.9 million, stock-based compensation expense of $6.7 million and deferred taxes of $5.7$4.4 million, which were partially offset by changes in operating assets and liabilities and other items totaling $1.5$1.9 million. Cash flows from operating activities were $6.4 million during the three months ended March 31, 2021 and primarily consisted of net income of $3.7 million, adjusted for certain non-cash items, including depreciation and amortization of $10.1 million, stock-based compensation expense of $5.6 million, which were partially offset by changes in operating assets and liabilities and other items totaling $13.0 million.

 

Cash flows from operating activities decreased $32.7increased $11.4 million during the sixthree months ended June 30, 2021March 31, 2022 compared to the same period in 2020,2021, primarily due to decreasesincreases in net income of $10.0$1.4 million and changes in operating assets and liabilities totaling $14.3 million, which were partially offset by decreases in accounts receivablestock-based compensation of $19.0 million driven by timing of cash receipts, a decrease in the fair value of contingent consideration of $7.8$1.2 million and decreases in deferred taxes of $5.2 million, which were partially offset by increases in depreciation and amortization of $4.3 million, increases in stock-based compensation of $3.9 million and increases of $1.1 million in other items.$3.1 million.

 

Cash Flows from Investing Activities

 

Cash used in investing activities was $105.1$25.8 million during the sixthree months ended June 30,March 31, 2022, consisting of $22.7 million for net purchases of marketable securities and $3.1 million for the purchases of property, equipment and other capital assets.

Cash used in investing activities was $90.1 million during the three months ended March 31, 2021, consisting of $127.4$127.7 million in cash used for acquisitions, net of cash acquired and $23.9$6.5 million for the purchases of property, equipment and other capital assets, which were partially offset by $46.2$44.1 million for net proceeds from investments in marketable securities.

 

Cash used in investing activities was $65.3 million during the six months ended June 30, 2020, consisting of $29.0 million in net investments in marketable securities, $33.3 million for the purchases of property, equipment and other capital assets and $3.0 million for purchases of other assets and investments.

24
22

 

Cash Flows from Financing Activities

 

Cash used in financing activities was $1.9$0.6 million during the sixthree months ended June 30,March 31, 2022, consisting of $0.5 million in shares withheld for tax obligations associated with equity transactions, and $0.1 million for repayments of finance lease obligations.

Cash used in financing activities was $0.4 million during the three months ended March 31, 2021, consisting of $4.2$2.0 million in purchases of shares withheld for tax obligations associated with equity transactions $1.2 million in repurchases of common stock and $0.3$0.1 million for repayments of finance lease obligations, which were partially offset by $3.8 million in proceeds from the exercise of stock options.

Cash used in financing activities was $15.2 million during the six months ended June 30, 2020, consisting of $14.7 million in repurchases of common stock and $3.4 million in purchases of shares withheld for tax obligations associated with equity transactions, which were partially offset by $2.9$1.7 million in proceeds from the exercise of stock options.

 

Off-Balance Sheet Arrangements

 

Since our inception, we have not engaged in any off-balance sheet arrangements, including the use of structured finance, special purpose entities or variable interest entities.

 

Critical Accounting Policies and Use of Estimates

 

We have adopted various accounting policies to prepare the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). Our significant accounting policies are disclosed in Note 2 to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2020.2021. There were no material changes to our critical accounting policies during the three months ended March 31, 2022.

 

Recent Accounting Pronouncements

 

For information on recent accounting pronouncements, see Note 2 to the Consolidated Financial Statements appearing in Part I, Item 1 in this Quarterly Report on Form 10-Q.

 

25
23

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Foreign Currency Risk

 

As a result of our foreign operations, we have revenue, expenses, assets and liabilities that are denominated in foreign currencies. We generate revenue and incur production costs and operating expenses in British Pounds, Euros and Japanese Yen.

 

Our operating results and cash flows are adversely impacted when the United States Dollar appreciates relative to foreign currencies. Additionally, our operating results and cash flows are adversely impacted when the British Pound appreciates relative to the Euro. As we expand internationally, our results of operations and cash flows will become increasingly subject to changes in foreign currency exchange rates.

 

We have not used forward contracts or currency borrowings to hedge our exposure to foreign currency risk. Foreign currency risk can be assessed by estimating the change in results of operations or financial position resulting from a hypothetical 10% adverse change in foreign exchange rates. We believe such a change would generally not have a material impact on our financial position, but could have a material impact on our results of operations. We recognized foreign currency gainslosses of $0.1$0.3 million and foreign currency losses of $0.5 million during the three and six months ended June 30,March 31, 2022 and 2021, respectively. We recognized foreign currency gains of $0.3 million and $0.9 million during the three and six months ended June 30, 2020, respectively.  The changes in foreign exchange rates had a positivenegative impact on consolidated revenue of $1.9$1.5 million for the three months ended June 30, 2021 and $3.5 million for the six months ended June 30, 2021March 31, 2022 as compared to the same periods in 2020.2021.

 

26
24

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this quarterly report, our disclosure controls and procedures are effective and provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported accurately and within the time frames specified in the SEC’s rules and forms and accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

During the first quarter of 2021, the Company completed the implementation of Protolabs 2.0, an internal business systems project impacting both external customer-facing and internal back-end systems. Emphasis has been on the maintenance of effective internal controls throughout development and deployment of all phases. The Company evaluated and concluded the implementation of Protolabs 2.0 has not materially affected the Company's internal control over financial reporting. Based on this evaluation, thereThere have been no changes in our internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Management has excluded certain elements of Hubs from its assessment of internal control over financial reporting as of June 30, 2021. Subsequent to the acquisition, Hubs maintained its revenue and payroll systems and processing through June 30, 2021. Those elements of the acquired business’s internal control over financial reporting that were not fully integrated into the Company’s existing internal control over financial reporting during 2021 have been excluded from management’s assessment of the effectiveness of internal control over financial reporting. Hubs is a wholly-owned subsidiary of the Company; its combined total assets, excluding goodwill, and total revenues excluded from our assessment represent approximately 4% and 6%, respectively, of the related consolidated financial statements amounts as of the six months ended June 30, 2021.

27
25

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we are subject to various legal proceedings and claims that arise in the ordinary course of our business activities. Although the results of litigation and claims cannot be predicted with certainty, as of the date of these financial statements, we do not believe we are party to any litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. 

 

Item 1A. Risk Factors

 

Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 20202021 includes a discussion of our risk factors. There have been no material changes from the risk factors described in our Form 10-K.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On February 9, 2017, we announced that our board of directors had authorized the repurchase of shares of our common stock from time to time on the open market or in privately negotiated purchases, at an aggregate purchase price of up to $50 million. On May 16, 2019, we announced that our board of directors approved a $50 million increase in its authorized stock repurchase program and extended the term of the program through December 31, 2023. This authorization increases2023, which increased the stock repurchase program to $100 million. On December 8, 2021, our board of directors approved a $50 million increase in its authorized stock repurchase program, which increased the total expenditure authorized to $150 million. We have $61.9 million remaining under this authorization. The timing and amount of any share repurchases will be determined by our management based on market conditions and other factors.

 

DuringThe Company had no repurchases in the three months ended June 30, 2021, we repurchased 14,000 sharesfirst quarter of our common stock at a total purchase price of $1.2 million under this program. Common stock repurchase activity through June 30, 2021 was as follows:

Period

 

Total Number of Shares Purchased

  

Average Price Paid per Share

  

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs

  

Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) (1)

 

April 1, 2021 through April 30, 2021

 -  $-  -  $35,175 

May 1, 2021 through May 31, 2021

 -  $-  -  $35,175 

June 1, 2021 through June 30, 2021

 14,000  $86.53  14,000  $33,964 
  14,000  $86.53  14,000  $33,964 

1 Effective May 15, 2019 the Board of Directors authorized the repurchase of shares of the Company’s common stock from time to time on the open market or in privately negotiated purchases, at an aggregate purchase price of up to $100 million. The term of the program runs through December 31, 2023.2022. 

 

Item 3. Defaults Upon Senior Securities

 

No matters to disclose.

 

Item 4. Mine Safety Disclosures

 

No matters to disclose.

 

Item 5. Other Information

 

No matters to disclose.

 

28
26

 

Item 6. Exhibits

 

The following documents are filed as part of this report:

 

Exhibit Number

 

Description of Exhibit

3.1(1)

 

Third Amended and Restated Articles of Incorporation of Proto Labs, Inc.

3.2(2)

 Articles of Amendment to Third Amended and Restated Articles of Incorporation of Proto Labs, Inc. dated May 20, 2015

3.3(3)

 

Second Amended and Restated By-Laws of Proto Labs, Inc., as amended through November 8, 2016

31.1

 

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley ActAct*

31.2

 

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley ActAct*

32.1

 

Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley ActAct*

101.INS Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

(1)

Previously filed as Exhibit 3.2 to the Company’s Registration Statement on Form S-1/A, (File No. 333-175745), filed with the Commission on February 13, 2012, and incorporated by reference herein.

(2)

Previously filed as Exhibit 3.1 to the Company's Form 8-K, (File No. 001-35435), filed with the Commission on May 21, 2015 and incorporated by reference herein.

(3)

Previously filed as Exhibit 3.1 to the Company's Form 8-K, (File No. 001-35435), filed with the Commission on November 8, 2016 and incorporated by reference herein.
*Filed herewith.

 

29
27

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Proto Labs, Inc.

 

 

 

 

 

Date: August 3, 2021May 6, 2022

 

/s/ Robert Bodor

 

 

 

Robert Bodor

 

 

 

President and Chief Executive Officer

(Principal Executive Officer)

 

 

Date: August 3, 2021May 6, 2022

 

/s/ John A. WayDaniel Schumacher

 

 

 

John A. Way

Daniel Schumacher

 

 

 

Interim Chief Financial Officer

(Principal Financial Officer)

 

 

 

3028